Fresh from the Queensland Winter Carnival where horse racing has taken centre stage in the state for the past month, veterinary clinic operator Apiam Animal Health (ASX: AHX) will be coming home with a prized trophy having acquired Scenic Rim Vets for $16 million. Scenic Rim Vets is made up of clinics in Beaudesert, a
Read More
The SOFY acronym may not be as well known as its cousin EOFY but similar opportunities exist for thematic investors to capitalise on stocks that benefit from the Start of Financial Year festivities. As a period dedicated to accountants that will be frantically logging receipts to fall within the FY21 reporting period, fintech provider Class
Read More
Promising early study results released today by clinical stage drug development company Pharmaxis (ASX: PXS), should be a reason for investors to stir. Pharmaxis’ latest clinical trial (MF-101) focuses on bone marrow cancer myelofibrosis and potential treatment with their hero drug, PXS-5505. Having already proven the drug’s tolerability and efficacy in terms of absorption, distribution,
Read More
With more pressure than ever on the healthcare system, scalability is everything. How can we expand the system to meet increased demands by users? Pacific Knowledge Systems (ASX: PKS) is addressing this complex issue through their technology stack by providing software applications to better capture, apply and manage human expertise to enhance business performance and
Read More
There’s been a small bump in the road in Cyclopharm’s (ASX: CYC) plans to secure regulatory approval for Technegas™, their proprietary technology for lung imaging. Technegas™ comprises ultra-fine radioactive labelled carbon that is exposed to high heat to create a gas that can be inhaled by the patient. The gas allows for comprehensive imaging to
Read More
Since the beginning of the pandemic, where trust in the public transport network sent Aussies towards new and used cars in droves, Autosports Group (ASX: ASG) is continuously brought upon by their excellent sales, adding dealership John Newell Mazda to their network via acquisition. The deal will secure 80% of the Mazda dealership for $12
Read More
Sadly, 1 in 7 women will be diagnosed with breast cancer at some stage in their life. That’s 1 in 7 mothers, daughters, aunties, girlfriends, wives, friends and nieces. In the last 10 years, breast cancer diagnosis has increased by 36% and remains the second most common cause of death from cancer among females. Health
Read More
After having a major contract with Nine Entertainment not be renewed, Southern Cross Media (ASX: SXL) has bounced back to land Network 10 for a regional affiliate deal that will offer the network a boost in advertising revenue. The 2-year deal with Network 10 comes after three months of negotiations which will see Southern Cross
Read More
Coming to an End of the Financial Year where Australians have spent more time working from home than ever before, many have cottoned on to the opportunity to claim sizable tax deductions by upgrading their home offices. And the big winner – Harris Technology (ASX: HT8). As the Number 1 ranked seller on Amazon Australia,
Read More
Online wagering company, BlueBet Holdings Limited (Proposed ASX: BBT), are the latest online wagering company to make their public debut, expected to list on the exchange on July 2. BlueBet were looking to raise $80M, asking $1.14 per share, giving the company an indicative market cap at completion of the offer of $228.1M. BlueBet was
Read More
